Prenatal exposure to lipopolysaccharide alters the intrarenal renin-angiotensin system and renal damage in offspring rats

Hypertension Research

Volumn 33, Issue 1, 2010, Pages 76-82

  Hao, Xue Qin ^a   Zhang, Hai Gang ^a   Yuan, Zhi Bing ^a   Yang, Dan Li ^a   Hao, Li Yun ^a   Li, Xiao Hui ^a  

^a THIRD MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Inflammation; Offspring; Prenatal stress; RAS

Indexed keywords

ANGIOTENSIN II; CREATININE; DIPEPTIDYL CARBOXYPEPTIDASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; KIDNEY RENIN; LIPOPOLYSACCHARIDE; MESSENGER RNA; PYRROLIDINE DITHIOCARBAMATE;

ANGIOTENSIN BLOOD LEVEL; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL COUNT; CELL LEVEL; CELLULAR DISTRIBUTION; CONTROLLED STUDY; CREATININE CLEARANCE; ENZYME ACTIVITY; FEMALE; GENE EXPRESSION; GESTATIONAL AGE; GLOMERULUS; HYPERTENSION; INFLAMMATION; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY INJURY; NEWBORN; NONHUMAN; PATHOPHYSIOLOGY; PREGNANCY; PRENATAL EXPOSURE; PROGENY; PROTEIN LOCALIZATION; PROTEIN URINE LEVEL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM;

ANGIOTENSIN II; ANIMALS; BLOOD PRESSURE; CREATINE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; FEMALE; IMMUNOHISTOCHEMISTRY; KIDNEY DISEASES; KIDNEY FUNCTION TESTS; KIDNEY GLOMERULUS; LIPOPOLYSACCHARIDES; NF-KAPPA B; PEPTIDYL-DIPEPTIDASE A; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEINURIA; PYRROLIDINES; RATS; RATS, SPRAGUE-DAWLEY; RENIN; RENIN-ANGIOTENSIN SYSTEM; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; THIOCARBAMATES;

EID: 74349101166     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1038/hr.2009.185     Document Type: Article

References (40)

1. Karthikeyan VJ, Lip GY. Oxidative stress and hypertension. Int J Clin Pract 2006; 60: 1525-1527.
2. Kang YM, Ma Y, Zheng JP, Elks C, Sriramula S, Yang ZM, Francis J. Brain nuclear factor-kappa B activation contributes to neurohumoral excitation in angiotensin II-induced hypertension. Cardiovasc Res 2009; 82: 503-512.
3. Mauno V, Hannu K, Esko K. Proinflammation and hypertension: a population-based study. Mediators Inflamm 2008; 2008: 619704.
4. Rizzo M, Corrado E, Coppola G, Muratori I, Novo G, Novo S. Markers of inflammation are strong predictors of subclinical and clinical atherosclerosis in women with hypertension. Coron Artery Dis 2009; 20: 15-20.
5. Pauletto P, Rattazzi M. Inflammation and hypertension: the search for a link. Nephrol Dial Transplant 2006; 21: 850-853.
6. Marchesi C, Paradis P, Schiffrin EL. Role of the renin-angiotensin system in vascular inflammation. Trends Pharmacol Sci 2008; 29: 367-374.
7. Wei YL, Li XH, Zhou JZ. Prenatal exposure to lipopolysaccharide results in increases in blood pressure and body weight in rats. Acta Pharmacol Sin 2007; 28: 651-656.
8. Liao W, Wei Y, Yu C, Zhou J, Li S, Pang Y, Li X. Prenatal exposure to zymosan results in hypertension in adult offspring rats. Clin Exp Pharmacol Physiol 2008; 35: 1413-1418.
9. Wu J, Yang X, Zhang YF, Zhou SF, Zhang R, Dong XQ, Fan JJ, Liu M, Yu XQ. Angiotensin II upregulates Toll-like receptor 4 and enhances lipopolysaccharide-induced CD40 expression in rat peritoneal mesothelial cells. Inflamm Res 2009; 58: 473-482. (e-pub ahead of print 7 March 2009).
10. Chan MY, Cross-Mellor SK, Kavaliers M, Ossenkopp KP. Lipopolysaccharide (LPS) blocks the acquisition of LiCl-induced gaping in a rodent model of anticipatory nausea. Neurosci Lett 2009; 450: 301-305.
11. Guzik TJ, Harrison DG. Endothelial NF-kB as a mediator of kidney damage: the missing link between systemic vascular and renal disease? Circ Res 2007; 101: 227-229.
12. Messina S, Bitto A, Aguennouz M, Minutoli L, Monici MC, Altavilla D, Squadrito F, Vita G. Nuclear factor kappa-B blockade reduces skeletal muscle degeneration and enhances muscle function in Mdx mice. Exp Neurol 2006; 198: 234-241.
13. Muller DN, Dechend R, Mervaala EM, Park JK, Schmidt F, Fiebeler A, Theuer J, Breu V, Ganten D, Haller H, Luft FC. NF-kappaB inhibition ameliorates angiotensin II-induced inflammatory damage in rats. Hypertension 2000; 35: 193-201.
14. Rodriguez-Iturbe B, Ferrebuz A, Vanegas V, Quiroz Y, Mezzano S, Vaziri ND. Early and sustained inhibition of nuclear factor-kappaB prevents hypertension in spontaneously hypertensive rats. J Pharmacol Exp Ther 2005; 315: 51-57.
15. Ortiz LA, Quan A, Weinberg A, Baum M. Effect of prenatal dexamethasone on rat renal development. Kidney Int 2001; 59: 1663-1669.
16. Ohira S, Kirk AB, Dasgupta PK. Automated measurement of urinary creatinine by multichannel kinetic spectrophotometry. Anal Biochem 2009; 384: 238-244.
17. Kanchana WI, Sakai T, Teshima N, Katoh S, Grudpan K. Successive determination of urinary protein and glucose using spectrophotometric sequential injection method. Anal Chim Acta 2007; 604: 139-146.
18. Yuan ZB, Zhang HG, Jia Y, Cheng YQ, Li XH. Temporal expression of cyclooxygenase-2 in peritoneal macrophages of rats and effects of panax notoginseng saponins. Inflamm Res 2009; 58: 74-80.
19. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid concentrations of angiotensins I and II in anesthetized rats. Hypertension 2002; 39: 129-134.
20. Hoffmann S, Podlich D, Hahnel B, Kriz W, Gretz N. Angiotensin II type 1 receptor overexpression in podocytes induces glomerulosclerosis in transgenic rats. J Am Soc Nephrol 2004; 15: 1475-1487.
21. Nishiyama A, Seth DM, Navar LG. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. J Am Soc Nephrol 2002; 13: 2207-2212.
22. Franco M, Martinez F, Quiroz Y, Galicia O, Bautista R, Johnson RJ, Rodriguez-Iturbe B. Renal angiotensin II concentration and interstitial infiltration of immune cells are correlated with blood pressure levels in salt-sensitive hypertension. Am J Physiol Regul Integr Comp Physiol 2007; 293: R251-R256.
23. Pena LA, Fuks Z, Kolesnick RN. Radiation-induced apoptosis of endothelial cells in the murine central nervous system: protection by fibroblast growth factor and sphingomye-linase deficiency. Cancer Res 2000; 60: 321-327.
24. Atlas SA. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm 2007; 13: 9-20.
25. Guron G, Molne J, Swerkersson S, Friberg P, Hansson S. A 14-year-old girl with renal abnormalities after brief intrauterine exposure to enalapril during late gestation. Nephrol Dial Transplant 2006; 21: 522-525.
26. Martinovic J, Benachi A, Laurent N, Daikha-Dahmane F, Gubler MC. Fetal toxic effects and angiotensin-II-receptor antagonists. Lancet 2001; 358: 241-242.
27. Woods LL, Ingelfinger JR, Nyengaard JR, Rasch R. Maternal protein restriction suppresses the newborn renin-angiotensin system and programs adult hypertension in rats. Pediatr Res 2001; 49: 460-467.
28. Kobori H, Prieto-Carrasquero MC, Ozawa Y, Navar LG. AT1 receptor mediated augmentation of intrarenal angiotensinogen in angiotensin II-dependent hypertension. Hypertension 2004; 43: 1126-1132.
29. Vanegas V, Ferrebuz A, Quiroz Y, Rodriguez-Iturbe B. Hypertension in Page (cellophane-wrapped) kidney is due to interstitial nephritis. Kidney Int 2005; 68: 1161-1170.
30. Kobori H, Nangaku M, Navar LG, Nishiyama A. The intrarenal renin-angiotensin system: from physiology to the pathobiology of hypertension and kidney disease. Pharmacol Rev 2007; 59: 251-287.
31. Yamamoto T, Hayashi K, Matsuda H, Kubota E, Tanaka H, Ogasawara Y, Nakamoto H, Suzuki H, Saruta T, Kajiya F. In vivo visualization of angiotensin II and tubuloglomerular feedback-mediated renal vasoconstriction. Kidney Int 2001; 60: 364-369.
32. Paul M, Poyan Mehr A, Kreutz R. Physiology of local renin-angiotensin systems. Physiol Rev 2006; 86: 747-803.
33. Edgley AJ, Kett MM, Anderson WP. Evidence for renal vascular remodeling in angiotensin II-induced hypertension. J Hypertens 2003; 21: 1401-1406.
34. Sarkis A, Liu KL, Lo M, Benzoni D. Angiotensin II and renal medullary blood flow in Lyon rats. Am J Physiol Renal Physiol 2003; 284: F365-F372.
35. Badzyńska MM. Differential effect of angiotensin II on blood circulation in the renal medulla and cortex of anaesthetized rats. J Physiol 2002; 538: 159-166.
36. Sorensen CM, Leyssac PP, Skott O, Holstein-Rathlou NH. Role of the renin-angiotensin system in regulation and autoregulation of renal blood flow. Am J Physiol Regul Integr Comp Physiol 2000; 279: R1017-R1024.
37. Suzuki K, Han GD, Miyauchi N, Hashimoto T, Nakatsue T, Fujioka Y, Koike H, Shimizu F, Kawachi H. Angiotensin II type 1 and type 2 receptors play opposite roles in regulating the barrier function of kidney glomerular capillary wall. Am J Pathol 2007; 170: 1841-1853.
38. Liang XB, Ma LJ, Naito T, Wang Y, Madaio M, Zent R, Pozzi A, Fogo AB. Angiotensin type 1 receptor blocker restores podocyte potential to promote glomerular endothelial cell growth. J Am Soc Nephrol 2006; 17: 1886-1895.
39. Durvasula RV, Petermann AT, Hiromura K, Blonski M, Pippin J, Mundel P, Pichler R, Griffin S, Couser WG, Shankland SJ. Activation of a local tissue angiotensin system in podocytes by mechanical strain. Kidney Int 2004; 65: 30-39.
40. Agrawal V, Marinescu V, Agarwal M, McCullough PA. Cardiovascular implications of proteinuria: an indicator of chronic kidney disease. Nat Rev Cardiol 2009; 6: 301-311.